References
- 1. Angell P, Chester N, Green D, Somauroo J, Whyte G, George K. (2012) Anabolic steroids and cardiovascular risk. Review. Sports Med. 42(2):119-34.
- 2. Nieschlag E, Vorona E. (2015) Doping With AAS: adverse effectson non-reproductive organs and function. Rev Endocr Metab Disord. 16(3):199-211.
- 3. Piacentino D, Kotzalidis GD, Del Casale A, Aromatario MR, Pomara C, Girardi P ,Sani G. (2015) Anabolic-androgenic steroids use and psychopathology in athlets. A systematic review. Curr Neuropharmacol. 13(1):101-21.
- 4. De Piccoli B1, Giada F, Benettin A, Sartori F, Piccolo E. (1991) Anabolic steroid use in body builders: an echocardiographic study of left ventricle morphology and function. Int J Sports Med 12 (4):408-12.
- 5. Rocha FL, Carmo EC, Roque FR, Hashimoto NY, Rossini LV, Frimm C, Aneas I, Neagro CE, Krieger JE, Oliveira EM. (2007) Anabolic steroids induce cardiac reninangiotensin system and impair the beneficial effects of aerobic training in rats. Am J Physiol Heart Circulation Physiol, 293(6):H3575-83.
- 6. Yesalis CE, Bahrke MS. (1995) Anabolic-androgenic steroids. Current issues.Sports Med. 19(5):326-40
- 7. Shahidi NT. (2001) A review of the chemistry, biological action, and clinical applications of anabolic-androgenic steroids. Clin Ther. 23(9):1355-90.
- 8. Stephan Pinheiro Frankenfeld, Leonardo Pires de Oliveira, Daniele Leão Ignacio, Raquel Guimarães Coelho, Mariana Nigro Mattos, Andrea Claudia Freitas Ferreira, Denise Pires Carvalho and Rodrigo Soares Fortunato. (2014) Nandrolone decanoate inhibits gluconeogenesis and decreases fasting glucose in Wistar male rats. J Endocrinol. 220(2):143-53.
- 9. Payne JR, Kotwinski PJ, Montgomery HE. (2004) Cardiac effects of anabolic steroid. Heart. 90 (5): 473-5
- 10. Tylicki A, Kawalko A, Sokolska J, Strumilo S. (2007) Effect of anabolic steroid nandrolone deaconate on enzymes in the heart, liver and muscle of rats and rat’s electrophysiology. Horm Metab Res. 39 (4):268-72
- 11. Frati P, Busardo FP, Cipolloni L, Dominicis ED, Fineschi V. (2015) Anabolic androgenic steroids ( AAS) related deaths: autoptic, histopathologycal and toxicologycal findings. Curr Neuropharmacol. 13(1):146-59
- 12. Fineschi V. (2013) Chronic, supra-physiological doses of nandrolone decanoate and exercise induced cardiotoxicity in an animal-model study. Acta Physiol (Oxf). 208(2):1413.
- 13. Phillis BD, Abeywardena MY, Adams MJ, Kennedy JA, Irvine RJ. (2007) Nandrolone potentiates arrhythmogenic effects of cardiac ischemia in the rat. Toxicol Sci 99(2):605- 11
- 14. Hassan AF1, Kamal MM. (2013) Effect of exercise training and anabolic androgenic steroids on hemodynamics, glycogen content, angiogenesis and apoptosis of cardiac muscle in adult male rats. Int J Health Sci (Qassim) 7(1):47-60.
- 15. Tanno AP, das Neves VJ, Rosa KT, Cunha TS, Giordano FC, Calil CM, Guzzoni V, Fenandes T, de Oliveira EM, Novaes PD, Irigoyen MC, Moura MJ, Marcondes FK. (2011) Nandrolone and resistance training induce heart remodeling: role of fetal genes and implications for cardiac pathophysiology. Life Sci 89(17-18):631-7.
- 16. Takahashi M, Tatsugi T, Kohno T. (2004) Endocrinological and pathological effects of anabolic-androgenic steroid in male rat. Endocr J. 51(4):425-34
- 17. Franquni JV, do Nascimento AM, de Lima EM, Brasil GA, Heringer OA, Cassaro KO, da Cunha TV, Musso C, Silva Santos MC, Kalil IC, Endringer DC, Boëchat GA, Bissoli NS, de Andrade TU. (2013) Nandrolone decanoate determines cardiac remodeling and injury by an imbalance in cardiac inflammatory cytokines and ACE activity, blunting of the Bezold-Jarisch reflex, resulting in the development of hypertension. Steroids. 78(3):379-85.
- 18. Fineschi V, Riezzo I, Centini F, Silingardi E, Licata M, Karch SB. ( 2005) Sudden cardiac death during anabolic steroid abuse: morphologic and toxicologic finding in two fatal cases of bodybuilders. Int J Legal Med. 15:1-6.
- 19. Pluim BM, Zwinderman AH, van der Laarse A, van der Wall EE. (2000) The athlete’s heart. A meta-analysis of cardiac structure and function. Circulation. 25;101(3):336-44.
- 20. Ellison GM, Waring CD, Vicinanza C, Torella D. (2012) Physiological cardiac remodeling in response to endurance Exercise training: cellular and molecular mechanisms. Heart. 98(1):5-10.
- 21. Cunha TS, Tanno AP, Costa Sampaio Moura MJ, Marcondes FK. (2005) Influence of high-intensity exercise training and anabolic androgenic steroid treatment on rat tissue glycogen content Life Sci. 77(9):1030-43.
- 22. Urhausen A, Hölpes R, Kindermann W. (1989) Oneand two-dimensional echocardiography in bodybuilders using anabolic steroids. Eur J Appl Physiol Occup Physiol. 58(6):633-40.
- 23. Montisci M, El Mazloum R, Cecchetto G, Terranova C, Ferrara SD, Thiene G, Basso C. (2012) Anabolic androgenic steroids abuse and cardiac death in athletes: morphological and toxicological findings in four fatal cases. Forensic Sci Int. 217(1-3):e13-8.
- 24. Nikolic T, Zivkovic V, Jevdjevic M, Djuric M, Srejovic I, Djuric D, Jeremic N, Djuric D, Bolevich S, Jakovljevic V. (2015) The effets of chronic administration of nandrolone decanoate on redox status on exercised rats. Mol Cell Biochem. [Epub ahead of print].
- 25. Ren R,Oakley RH,Cruz-Topete D,Cidlowski JA. (2012) Dual role for glucocorticoids in cardiomyocyte hypertrophy and apoptosis. Endocrinology. 153(11):5346-60.